Company / Gross Profit
Sanara MedTech Inc. Gross Profit History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$78.5M
FY2025
5-year range
$14.0M / $78.5M
FY2021-FY2025
Trend
+37.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 9 consecutive years, from $2M in FY2015 to $79M in FY2025.
Based on SEC 10-K filings.
$79M in FY2025 with a 10-year CAGR of +45.6%.
Improved from $39M to $79M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +53.2%
- 5-Year CAGR
- +49.4%
- 10-Year CAGR
- +45.6%
Key checks
Key Insights
- Sanara MedTech Inc.'s gross profit has grown for 9 consecutive years.
- 5-year CAGR of +49.4%, indicating consistent growth.
- In FY2025, gross profit increased 37.4% year-over-year.
- Lowest gross profit in the period was in FY2015.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $78.5M | +37.4% |
| FY2024 | $57.1M | +44.7% |
| FY2023 | $39.5M | +80.8% |
| FY2022 | $21.8M | +56.3% |
| FY2021 | $14.0M | +32.3% |
| FY2020 | $10.6M | +92.0% |
| FY2018 | $5.5M | +20.5% |
| FY2017 | $4.6M | +84.0% |
| FY2016 | $2.5M | +35.6% |
| FY2015 | $1.8M | +95.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026